Stop the killer: how to inhibit the anthrax lethal factor metalloprotease
Cesare Montecucco1, Fiorella Tonello, Giuseppe Zanotti
1Istituto Veneto di Medicina Molecolare, Via Orus, 35121 Padua, Italy. cesare.montecucco@unipd.it
Abstract:
Inhalation of anthrax spores rapidly develops into a deadly bacteraemia and toxaemia. Anthrax toxins include the lethal factor (LF), a mitogen-activated protein kinase (MAPK)-kinase-specific metalloprotease, which acts in the cell cytosol and plays a major part in anthrax pathogenesis. Recently, screening methods have led to the discovery of LF inhibitors that are membrane permeable. This will pave the way for design of novel anthrax therapeutics that are capable of inhibiting the metalloprotease activity of LF in vivo.
Related Concept Videos
Inhalation Anthrax
Inhibitors of Bacterial Protein Synthesis
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Bacterial Toxins
Antiprotozoal Agents
Gene Regulation in Microbial Communities: Quorum Sensing


